The U.S. Supreme Court just delivered a crushing blow to consumers harmed by generic drugs. Mass tort attorneys at Pintas & Mullins Law Firm are disappointed in the Court’s ruling, which strips innocent victims of their legal right to sue generic drug-makers. Consumers may still sue brand name drug makers for failing to warn them of possible …
Abbott Likely Settling Illegal Depakote Marketing
Drug recall lawyers at Pintas & Mullins Law Firm have evidence from court documents that the company accused of illegally marketing the dangerous anti-seizure drug Depakote is actively engaged in settlement talks with the government. A federal probe recently revealed that the Illinois-based company Abbott Laboratories violated the law by promoting Depakote for unapproved uses. The …
New Avandia Class Action Lawsuit Filed in Illinois
A new Illinois class action lawsuit filed against the makers of the controversial diabetes drug Avandia joins more than a thousand Avandia cases pending in courts throughout the country. Like nearly all of the personal injury lawsuits facing GlaxoSmithKline, the latest Avandia complaint alleges improper marketing. More than 43 Illinois Avandia users claim that GlaxoSmithKline failed to …
Wisconsin Drug Firms Manufacturing Halted
Federal officials are taking legal action against a drug manufacturer and distributor that exposed consumers to potentially life-threatening bacteria. Triad Group Inc. and H &P Industries of Hartland, Wisconsin, are accused of violating federal safety standards by distributing contaminated medical products. The companies are owned and operated by the same entity and have a history …
Avandia Pulled From Pharmacy Shelves Nationwide
Thousands of patients have already suffered the adverse effects of Avandia, a popular diabetes drug that poses a serious heart attack risk. Now the federal government is finally stepping in, with an announcement that it will pull Avandia from retail pharmacy store shelves beginning November 18. The drug will be available only through a special …
Drug Makers Disclose Payments to Doctors
It is routine practice for drug developers to pay doctors hundreds of millions of dollars a year to “educate” their fellow physicians about a company drug, in the hopes that they will consider prescribing the drug to patients. These “pill-pushing” payouts are extremely controversial. Critics of the pharmaceutical industry say the payments are nothing more …
FDA Warnings against Simultaneous Use of Plavix and Prilosec or Nexium
Millions of Americans take the blood thinner Plavix to reduce their risk of blood clots, which may lead to heart attack or stroke. Since Plavix can lead to an upset stomach, doctors often prescribe Prilosec and Nexium to treat this symptom. However, the FDA recently issued warnings that these medications may decrease the anti-clotting benefits …
Accutane and Increased Risk of Inflammatory Bowel Disease
In June of this year, Roche Holding quietly pulled the drug Accutane from the market. Accutane is prescribed to treat moderate to severe cases of acne. The drug has had an extensive history of leading to adverse effects since its approval in 1982, such as suicidal behavior and birth defects. The removal of the drug …
Federal Investigation into Marketing Practices of Depakote
The Chicago Tribune recently reported that Abbott Laboratories is under investigation for their sale and marketing practices of Depakote. Depakote is prescribed primarily to treat bipolar disorder. In certain cases, it is also used to treat major depressive disorder, epilepsy, chronic pain associated with neuropathy, and migraine headaches. The federal probe was initiated to find …
Zicam Shareholder Lawsuit
On Thursday of last week, a federal appeals court unanimously voted to reinstate a shareholder lawsuit against Matrixx Initiatives, the makers of the popular cold remedy Zicam. The lawsuit claims that the shareholders of the company did not disclose information that the drug was potentially harmful to the public and instead issued incorrect and misleading …
Taking Aranesp Increases Your Risk of Suffering a Stroke
A new study published last week pointed to an increased risk of stroke for patients taking the medication Aranesp. Aranesp is part of a class of drugs known as erythropoiesis-stimulating agents (ESAs), which stimulate the body to produce more red blood cells. ESAs are primarily used to treat anemia in patients with chronic kidney failure, …
Anti-Depressants and Suicide
The FDA recently mandated that all manufacturers of a class of anti-depressant drugs called Selective Seratonin Reuptake Inhibitors (SSRI’s) to include warnings of suicide and suicide ideation on their labels. Well known SSRI’s include Paxil, Prozac, Zoloft, Wellbutrin and Effexor. Not only are these drugs linked to an increased suicide risk, but “off-label” use is widespread meaning …
- « Previous Page
- 1
- …
- 6
- 7
- 8